Posts by Admin BioAlps
Gene Predictis – Tests génétiques pour prévenir les risques liés aux effets adverse
Des tests pour réduire les risques d’effets nocifs liés aux médicaments et à la nutrition. Un article de l’AGEFI La société, basée à l’Innovation Park de l’EPFL, propose une solution essentielle pour permettre la diminution des cas liés entre autre aux effets secondaires des médicaments. Article complet sur agefi.com
Read MoreMedtec Japan Tokyo 2018
The exhibition will take place from 18 to 20 April at the Big Sight Exhibition Centre in Tokyo, Japan. BioAlps will be present at the Swiss Medtech Pavillon and represented by the Swiss Science & Technology Tokyo Office of the Swiss Embassy in Japan. A poster depicting the Life Sciences cluster highlighting its community, our…
Read MoreSelexis SA hires new strategic partners to strengthen its cell line development services
Selexis SA announced on 11 April that “it has made key strategic hires, signed its one hundredth commercial license agreement (CLA) and purchased and installed million in new laboratory equipment following its acquisition by JSR Corporation in June 2017. Specifically, the company hired new employees, to be based in Geneva, the U.S. and Tokyo, in the areas of…
Read MoreCMEF 2018
China Medical Equipment Fair 2018 Shanghai – China April 11-14, 2018 China International Medicinal Equipment Fair (CMEF), founded in 1979, is held twice a year – spring and autumn. After years of continuous innovation and self-improvement, CMEF has become the largest exhibition of medical equipment, related products and services in the Asia-Pacific region with an…
Read MoreFerring acquires Rebiotix Inc.
Ferring announces their acquisition of Rebiotix Inc., microbiome pioneer. “This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions for patients.” Read the full press release
Read MoreADDEX THERAPEUTICS Sucessfully Raises CHF40 million in Capital Increase
“This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates through important value inflection points, including completing Phase 3 registration studies for dipraglurant,” said Tim Dyer, CEO of Addex Read full press release
Read MoreLe Biopôle recrute un/une “Marketing & Communication Manager – 80% “
La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle Plus d’informations
Read MoreMEDTRONIC – Open Innovation Days
Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018 Medtronic is among the world’s largest medical technology, services, and solutions companies. They deliver innovative services and solutions to hospitals, physicians, clinicians, and patients in approximately 160 countries, employing more than 84,000 people, including over 9,600 scientists and engineers.…
Read MoreGenomic Health: New Real-World Clinical Practice Data
Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions,…
Read MoreDiscover regenHU’s 3DDiscovery Evolution bio-printer
regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany. regenHU’s 3DDiscoveryTM Evolution, a revolutionary new generation of bio-printing equipment, is pushing the boundaries of tissue enginering and regenerative medicine to facilitate complex biofabrication of living tissues; one step closer to tissue and organ fabrication. The convergence of…
Read More